STOCK TITAN
  1. Home
  2. NRXPW

NRX Pharmaceuticals Warrant (NRXPW) Stock Price, News & Analysis

NRXPW

NRX Pharmaceuticals Warrant (NRXPW) last traded on May 22, 2026. A Form 25-NSE filed on May 22, 2026 removes its shares from exchange listing.

Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
147 229 sessions, May 22, 2025 to May 22, 2026
Largest daily move
+137.7% close of April 21, 2026
1-year change
-96.6% closing prices, May 22, 2025 to May 22, 2026
1-month change
-69.4% closing prices, April 22, 2026 to May 22, 2026

Company Description

NRX Pharmaceuticals Warrant (NRXPW) is classified in the pharmaceutical preparations industry.

NRXPW declined 96.6% in the 12 months to May 22, 2026. The last closing price was $0.0026.

For FY2025, NRX Pharmaceuticals Warrant reported revenue of $1.2M with net income of -$28.6M.

This page collects what Stock Titan holds for NRXPW, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

Chart
$0.0026
No recent trading
Last close: May 22, 2026
-96.6%
1 year to May 22, 2026
-
Market Cap
-
Shares outstanding

NRX Pharmaceuticals Warrant (NRXPW) closed at $0.0026 on May 22, 2026. In the 12 months to May 22, 2026, the price lost 96.6%.

See what a $1,000 investment in NRXPW would be worth today

Average down calculator for NRXPW

NRXPW Metrics & Rankings

Revenue
$1.2M
#3,714
Piotroski F-Score
3/6 Partial
#5,128
May 2026
-81.8%
—
YTD
-96.3%
—

Price returns through May 22, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

View All

No recent news available for NRXPW.

SEC Filings

View All

[8-K] NRx Pharmaceuticals (NASDAQ: NRXP) closes $22.3M stock sale

[424B5] NRx Pharmaceuticals (NASDAQ: NRXP) sells 5.7M shares at $3.50

[8-K] NRx Pharmaceuticals (NASDAQ: NRXP) plans stock sale with 15% underwriter option

[424B5] NRx Pharmaceuticals (NRXP) readies underwritten shelf offering; pricing pending

[25-NSE] Nasdaq withdraws NRXP Warrant listing (NRXP) — Form 25 notice

[10-Q] NRx Pharmaceuticals (NRXP) Q1 2026 loss narrows but going concern warning remains

[SCHEDULE 13G/A] Anson Funds discloses 1.74M shares in NRX Pharmaceuticals (NRXP)

[DEF 14A] NRx Pharmaceuticals (NASDAQ: NRXP) outlines 2025 votes on board, pay, equity plan

[4] NRX Pharmaceuticals (NRXP) COO awarded 100,000 stock options

[3] NRX Pharmaceuticals (NRXP) COO discloses 100,000-share stock option position

NRX Pharmaceuticals Warrant has filed 10 recent SEC filings, including 2 Form 8-K, 2 Form 424B5, 1 Form 3, 1 Form 4. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NRXPW SEC filings →

Financial Highlights

View Full Financials

NRX Pharmaceuticals Warrant generated $1.2M in revenue in FY2025, retaining a 58.8% gross margin, operating income reached -$16.2M, and net income was -$28.6M. The company generated -$14.1M in operating cash flow. The current ratio was 0.31, measuring current assets divided by current liabilities.

$1.2M
Revenue (FY2025)
-$28.6M
Net Income (FY2025)
-$14.1M
Operating Cash Flow
58.8%
Gross Profit Margin
0.31
Current Ratio
$720K
Gross Profit (FY2025)

Upcoming Events

No upcoming events scheduled for NRXPW.

Short Interest History

Last 12 Months

Short interest in NRX Pharmaceuticals Warrant (NRXPW) currently stands at 5.2 thousand shares, down 83.1% from the previous reporting period. Since November 2025, short interest has increased by 116.0%.

Days to Cover History

Last 12 Months

Days to cover for NRX Pharmaceuticals Warrant (NRXPW) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 23.7%.

NRXPW Company Profile & Sector Positioning

NRX Pharmaceuticals Warrant (NRXPW) .

Frequently Asked Questions

NRX Pharmaceuticals Warrant (NRXPW) last traded on May 22, 2026. A Form 25-NSE filed on May 22, 2026 removes its shares from exchange listing.

NRX Pharmaceuticals Warrant (NRXPW) has no recent trading. Its last close was $0.0026 on May 22, 2026.

The FY2025 revenue of NRX Pharmaceuticals Warrant (NRXPW) is $1.2M, from its most recent completed fiscal year.

The FY2025 net income of NRX Pharmaceuticals Warrant (NRXPW) is -$28.6M, from its most recent completed fiscal year.

The operating cash flow of NRX Pharmaceuticals Warrant (NRXPW) is -$14.1M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of NRX Pharmaceuticals Warrant (NRXPW) is 58.8% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of NRX Pharmaceuticals Warrant (NRXPW), current assets divided by current liabilities, was 0.31 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of NRX Pharmaceuticals Warrant (NRXPW) is $720K for FY2025, its most recent completed fiscal year.

The operating income of NRX Pharmaceuticals Warrant (NRXPW) is -$16.2M for FY2025, its most recent completed fiscal year. Learn about operating income.